Equities

Zepp Health Corp

Zepp Health Corp

Actions
Consumer DiscretionaryLeisure Goods
  • Price (USD)3.27
  • Today's Change-0.04 / -1.21%
  • Shares traded14.63k
  • 1 Year change-27.01%
  • Beta0.6080
Data delayed at least 15 minutes, as of Sep 19 2024 00:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Sep-23
  • 20-Jun-24
  • 18-Jul-24
  • 15-Aug-24
  • 12-Sep-24
Select bar for recommendation details.
Recommendations12-Sep-24
Buy0
Outperform1
Hold0
Sell0
Strong Sell0

Share price forecast in CNY

The one analyst offering a 12 month price target expects Zepp Health Corp - ADR share price to rise to 16.71 in the next year from the last price of 3.27.
High410.9%16.71
Med410.9%16.71
Low410.9%16.71

Earnings history & estimates in CNY

On Mar 18, 2024, earnings of 0.24 per share.
The next earnings announcement is expected on Mar 20, 2025.
Average growth rate-382.33%
Zepp Health Corp - ADR reported annual 2023 losses of -10.04 per share on Mar 18, 2024.
Average growth rate+112.32%
More ▼

Revenue history & estimates in CNY

Huami Corporationis an ADR and lacks the necessary revenue information for analysis.
Average growth rate-2.35%
Huami Corporation had revenues for the full year 2023 of 2.50bn. This was 39.77% below the prior year's results.
Average growth rate-16.41%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.